Stakes are high ahead of FDA panel vote on ALS drug
Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
Mar 28, 2022
0
13